<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36516294</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Impaired ribosome-associated quality control of C9orf72 arginine-rich dipeptide-repeat proteins.</ArticleTitle><Pagination><StartPage>2897</StartPage><EndPage>2912</EndPage><MedlinePgn>2897-2912</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awac479</ELocationID><Abstract><AbstractText>Protein quality control pathways have evolved to ensure the fidelity of protein synthesis and efficiently clear potentially toxic protein species. Defects in ribosome-associated quality control and its associated factors have been implicated in the accumulation of aberrant proteins and neurodegeneration. C9orf72 repeat-associated non-AUG translation has been suggested to involve inefficient translation elongation, lead to ribosomal pausing and activation of ribosome-associated quality control pathways. However, the role of the ribosome-associated quality control complex in the processing of proteins generated through this non-canonical translation is not well understood. Here we use reporter constructs containing the C9orf72-associated hexanucleotide repeat, ribosome-associated quality control complex deficient cell models and stain for ribosome-associated quality control markers in C9orf72-expansion carrier human tissue to understand its role in dipeptide-repeat protein pathology. Our studies show that canonical ribosome-associated quality control substrates products are efficiently cleared by the ribosome-associated quality control complex in mammalian cells. Furthermore, using stalling reporter constructs, we show that repeats associated with the C9orf72-expansion induce ribosomal stalling when arginine (R)-rich dipeptide-repeat proteins are synthesized in a length-dependent manner. However, despite triggering this pathway, these arginine-rich dipeptide-repeat proteins are not efficiently processed by the core components of the ribosome-associated quality control complex (listerin, nuclear-export mediator factor and valosin containing protein) partly due to lack of lysine residues, which precludes ubiquitination. Deficient processing by this complex may be implicated in C9orf72-expansion associated disease as dipeptide-repeat protein inclusions were observed to be predominantly devoid of ubiquitin and co-localize with nuclear-export mediator factor in mutation carriers' frontal cortex and cerebellum tissue. These findings suggest that impaired processing of these arginine-rich dipeptide-repeat proteins derived from repeat-associated non-AUG translation by the ribosome-associated quality control complex may contribute to protein homeostasis dysregulation observed in C9orf72-expansion amyotrophic lateral sclerosis and frontotemporal degeneration neuropathogenesis.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viera Ortiz</LastName><ForeName>Ashley P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Neuropathology Research Laboratory, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cajka</LastName><ForeName>Gregory</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olatunji</LastName><ForeName>Olamide A</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Translational Neuropathology Research Laboratory, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikytuck</LastName><ForeName>Bailey</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Translational Neuropathology Research Laboratory, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shalem</LastName><ForeName>Ophir</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Edward B</ForeName><Initials>EB</Initials><Identifier Source="ORCID">0000-0002-4589-1180</Identifier><AffiliationInfo><Affiliation>Translational Neuropathology Research Laboratory, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG072979</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP2 GM137416</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG065341</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS095793</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG066597</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012270" MajorTopicYN="N">Ribosomes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">
          C9orf72
        </Keyword><Keyword MajorTopicYN="N">ALS/FTD</Keyword><Keyword MajorTopicYN="N">NEMF</Keyword><Keyword MajorTopicYN="N">RAN translation</Keyword><Keyword MajorTopicYN="N">ribosome-associated quality control</Keyword></KeywordList><CoiStatement>The authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>14</Day><Hour>14</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36516294</ArticleId><ArticleId IdType="pmc">PMC10316761</ArticleId><ArticleId IdType="doi">10.1093/brain/awac479</ArticleId><ArticleId IdType="pii">6896481</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Joazeiro CAP. Ribosomal stalling during translation: Providing substrates for ribosome-associated protein quality control. Annu Rev Cell Dev Biol. 2017;33:343&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pubmed">28715909</ArticleId></ArticleIdList></Reference><Reference><Citation>Joazeiro CAP. Mechanisms and functions of ribosome-associated protein quality control. Nat Rev Mol Cell Biol. 2019;20:368&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7138134</ArticleId><ArticleId IdType="pubmed">30940912</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitron CS, Brandman O. Detection and degradation of stalled nascent chains via ribosome-associated quality control. Annu Rev Biochem. 2020;89:417&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8258965</ArticleId><ArticleId IdType="pubmed">32569528</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbeck S, Cerullo F, Pfeffer S, Joazeiro CAP. Ribosome-associated quality-control mechanisms from bacteria to humans. Mol Cell. 2022;82:1451&#x2013;1466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034055</ArticleId><ArticleId IdType="pubmed">35452614</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Gibbens B, Doty NS, et al. . Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci U S A. 2011;108:260&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3017129</ArticleId><ArticleId IdType="pubmed">21173221</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik I, Kelley CP, Wang ET, Todd PK. Molecular mechanisms underlying nucleotide repeat expansion disorders. Nat Rev Mol Cell Biol. 2021;22:589&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9612635</ArticleId><ArticleId IdType="pubmed">34140671</ArticleId></ArticleIdList></Reference><Reference><Citation>Banez-Coronel M, Ranum LPW. Repeat-associated non-AUG (RAN) translation: Insights from pathology. Lab Investig. 2019;99:929&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7219275</ArticleId><ArticleId IdType="pubmed">30918326</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd PK, Oh SY, Krans A, et al. . CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron. 2013;78:440&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3831531</ArticleId><ArticleId IdType="pubmed">23602499</ArticleId></ArticleIdList></Reference><Reference><Citation>Ba&#xf1;ez-Coronel M, Ayhan F, Tarabochia AD, et al. . RAN translation in Huntington disease. Neuron. 2015;88:667&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684947</ArticleId><ArticleId IdType="pubmed">26590344</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat Rev Neurol. 2018;14:544&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Jansen-West K, Xu YF, et al. . Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol. 2014;128:505&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159567</ArticleId><ArticleId IdType="pubmed">25173361</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang YJ, et al. . Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013;126:829&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKenzie IR, Arzberger T, Kremmer E, et al. . Dipeptide repeat protein pathology in C9ORF72 mutation cases: Clinico-pathological correlations. Acta Neuropathol. 2013;126:859&#x2013;879.</Citation><ArticleIdList><ArticleId IdType="pubmed">24096617</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. . Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Rothstein JD. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat Rev Neurosci. 2016;17:383&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376590</ArticleId><ArticleId IdType="pubmed">27150398</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Liu Y, Banez-Coronel M, et al. . RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A. 2013;110:E4968&#x2013;E4977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, et al. . Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Publ Gr. 2018;24:313&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, O&#x2019;Rourke JG, Meera P, et al. . Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med. 2013;5:208ra149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R, et al. . GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Frick P, Gr&#xe4;sser FA, et al. . Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol. 2015;130:845&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Eshov A, Zhou J, Isiktas AU, Guo JU. C9orf72 arginine-rich dipeptide repeats inhibit UPF1-mediated RNA decay via translational repression. Nat Commun. 2020;11:3354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7335171</ArticleId><ArticleId IdType="pubmed">32620797</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K, Zamiri B, Stanley SYR, Macgregor RB, Pearson CE. The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. J Biol Chem. 2013;288:9860&#x2013;9866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3617286</ArticleId><ArticleId IdType="pubmed">23423380</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd DW, Tomchick DR, Corey DR, Gagnon KT. Pathogenic C9ORF72 antisense repeat RNA forms a double helix with tandem C:C mismatches. Biochemistry. 2016;55:1283&#x2013;1286.</Citation><ArticleIdList><ArticleId IdType="pubmed">26878348</ArticleId></ArticleIdList></Reference><Reference><Citation>Endoh T, Sugimoto N. Mechanical insights into ribosomal progression overcoming RNA G-quadruplex from periodical translation suppression in cells. Sci Rep. 2016;6(June 2015):6&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4780275</ArticleId><ArticleId IdType="pubmed">26948955</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Goodrich KJ, Conlon EG, et al. . C9orf72 and triplet repeat disorder RNAs: G-quadruplex formation, binding to PRC2 and implications for disease mechanisms. Rna. 2019;25:935&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6633194</ArticleId><ArticleId IdType="pubmed">31048495</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Gotoh S, Yamashita T, et al. . The porphyrin TMPyP4 inhibits elongation during the noncanonical translation of the FTLD/ALS-associated GGGGCC repeat in the C9orf72 gene. J Biol Chem. 2021;297:101120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8446798</ArticleId><ArticleId IdType="pubmed">34450161</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Lee J, Kim J, Lee J, Park H, Lim C. ZNF598 co-translationally titrates poly(GR) protein implicated in the pathogenesis of C9ORF72-associated ALS/FTD. Nucleic Acids Res. 2021;49:11294&#x2013;11311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8565315</ArticleId><ArticleId IdType="pubmed">34551427</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtson MH, Joazeiro CAP. Role of a ribosome-associated E3 ubiquitin ligase in protein quality control. Nature. 2010;467:470&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2988496</ArticleId><ArticleId IdType="pubmed">20835226</ArticleId></ArticleIdList></Reference><Reference><Citation>Defenouill&#xe8;re Q, Zhang E, Namane A, Mouaikel J, Jacquier A, Fromont-Racine M. Rqc1 and Ltn1 prevent C-terminal alanine-threonine tail (CAT-tail)-induced protein aggregation by efficient recruitment of Cdc48 on stalled 60 s subunits. J Biol Chem. 2016;291:12245&#x2013;12253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4933273</ArticleId><ArticleId IdType="pubmed">27129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Doamekpor SK, Lee JW, Hepowit NL, et al. . Structure and function of the yeast listerin (Ltn1) conserved N-terminal domain in binding to stalled 60S ribosomal subunits. Proc Natl Acad Sci U S A. 2016;113:E4151&#x2013;E4160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4961192</ArticleId><ArticleId IdType="pubmed">27385828</ArticleId></ArticleIdList></Reference><Reference><Citation>Thrun A, Garzia A, Kigoshi-Tansho Y, et al. . Convergence of mammalian RQC and C-end rule proteolytic pathways via alanine tailing. Mol Cell. 2021;81:2112&#x2013;2122.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141035</ArticleId><ArticleId IdType="pubmed">33909987</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen PS, Park J, Qin Y, et al. . Rqc2p and 60S ribosomal subunits mediate mRNA-independent elongation of nascent chains. Science. 2015;347:75&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4451101</ArticleId><ArticleId IdType="pubmed">25554787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostova KK, Hickey KL, Osuna BA, et al. . CAT-tailing as a fail-safe mechanism for efficient degradation of stalled nascent polypeptides. Science. 2017;357:414&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5673106</ArticleId><ArticleId IdType="pubmed">28751611</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitron CS, Brandman O. CAT tails drive degradation of stalled polypeptides on and off the ribosome. Nat Struct Mol Biol. 2019;26:450&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6554034</ArticleId><ArticleId IdType="pubmed">31133701</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonashiro R, Tahara EB, Bengtson MH, et al. . The Rqc2/Tae2 subunit of the ribosome-associated quality control (RQC) complex marks ribosome-stalled nascent polypeptide chains for aggregation. eLife. 2016;5(e11794):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4805532</ArticleId><ArticleId IdType="pubmed">26943317</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao S, Brown A, Santhanam B, Hegde RS. Structure and assembly pathway of the ribosome quality control complex. Mol Cell. 2015;57:433&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4321881</ArticleId><ArticleId IdType="pubmed">25578875</ArticleId></ArticleIdList></Reference><Reference><Citation>Defenouillere Q, Yao Y, Mouaikel J, et al. . Cdc48-associated complex bound to 60S particles is required for the clearance of aberrant translation products. Proc Natl Acad Sci U S A. 2013;110:5046&#x2013;5051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3612664</ArticleId><ArticleId IdType="pubmed">23479637</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma R, Reichermeier KM, Burroughs AM, et al. . Vms1 and ANKZF1 peptidyl-tRNA hydrolases release nascent chains from stalled ribosomes. Nature. 2018;557:446&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6226276</ArticleId><ArticleId IdType="pubmed">29632312</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitron CS, Park JH, Giafaglione JM BO. Aggregation of CAT tails blocks their degradation and causes proteotoxicity in S. cerevisiae. PLoS ONE. 2019;15:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6964901</ArticleId><ArticleId IdType="pubmed">31945107</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin PB, Kigoshi-Tansho Y, Sher RB, et al. . NEMF mutations that impair ribosome-associated quality control are associated with neuromuscular disease. Nat Commun. 2020;11:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7494853</ArticleId><ArticleId IdType="pubmed">32934225</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimal S, Li Y, Vartak R, et al. . Inefficient quality control of ribosome stalling during APP synthesis generates CAT-tailed species that precipitate hallmarks of Alzheimer&#x2019;s disease. Acta Neuropathol Commun. 2021;9:1&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522249</ArticleId><ArticleId IdType="pubmed">34663454</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J, Hong NA, Masuda CA, et al. . A mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration. Proc Natl Acad Sci U S A. 2009;106:2097&#x2013;2103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2650114</ArticleId><ArticleId IdType="pubmed">19196968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A, Wang M, Bergant G, et al. . Biallelic loss-of-function variants in NEMF cause central nervous system impairment and axonal polyneuropathy. Hum Genet. 2021;140:579&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pubmed">33048237</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein KC, Morales-polanco F, Van Der Lienden J, Rainbolt TK. Ageing exacerbates ribosome pausing to disrupt cotranslational proteostasis. Nature. 2022;601:637&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8918044</ArticleId><ArticleId IdType="pubmed">35046576</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Tantray I, Lim J, et al. . MISTERMINATE Mechanistically links mitochondrial dysfunction with proteostasis failure. Mol Cell. 2019;75:835&#x2013;848.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362879</ArticleId><ArticleId IdType="pubmed">31378462</ArticleId></ArticleIdList></Reference><Reference><Citation>Radwan M, Ang CS, Ormsby AR, et al. . Arginine in C9ORF72 dipolypeptides mediates promiscuous proteome binding and multiple modes of toxicity. Mol Cell Proteomics. 2020;19:640&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7124463</ArticleId><ArticleId IdType="pubmed">32086375</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Wu Z, Tantray I, et al. . Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD. Proc Natl Acad Sci U S A. 2020;117:25104&#x2013;25115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547246</ArticleId><ArticleId IdType="pubmed">32958650</ArticleId></ArticleIdList></Reference><Reference><Citation>Loveland AB, Svidritskiy E, Susorov D, et al. . Ribosome inhibition by C9ORF72-ALS/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM. Nat Commun. 2022;13:2776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9120013</ArticleId><ArticleId IdType="pubmed">35589706</ArticleId></ArticleIdList></Reference><Reference><Citation>Juszkiewicz S, Hegde RS. Initiation of quality control during poly(A) translation requires site-specific ribosome ubiquitination. Mol Cell. 2017;65:743&#x2013;750.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316413</ArticleId><ArticleId IdType="pubmed">28065601</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali CP, Park DS, Lee EB. Targeted DNA methylation of neurodegenerative disease genes via homology directed repair. Nucleic Acids Res. 2019;47:11609&#x2013;11622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145628</ArticleId><ArticleId IdType="pubmed">31680172</ArticleId></ArticleIdList></Reference><Reference><Citation>Edie S, Zaghloul NA, Leitch CC, et al. . Survey of human chromosome 21 gene expression effects on early development in Danio rerio. G3 Genes|Genomes|Genetics. 2018;8:2215&#x2013;2223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027891</ArticleId><ArticleId IdType="pubmed">29760202</ArticleId></ArticleIdList></Reference><Reference><Citation>Darwich NF, Phan JM, Kim B, et al. . Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau. Science. 2020;370:eaay8826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7818661</ArticleId><ArticleId IdType="pubmed">33004675</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8:2281&#x2013;2308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969860</ArticleId><ArticleId IdType="pubmed">24157548</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Ward ME, Chen R, et al. . Scalable production of iPSC-derived human neurons to identify tau-lowering compounds by high-content screening. Stem Cell Rep. 2017;9:1221&#x2013;1233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5639430</ArticleId><ArticleId IdType="pubmed">28966121</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian R, Gachechiladze MA, Ludwig CH, et al. . CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons. Neuron. 2019;104:239&#x2013;255.e12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6813890</ArticleId><ArticleId IdType="pubmed">31422865</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandopulle MS, Prestil R, Grunseich C, Wang C, Gan L, Ward ME. Transcription factor&#x2013;mediated differentiation of human iPSCs into neurons. Curr Protoc Cell Biol. 2018;79:e51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993937</ArticleId><ArticleId IdType="pubmed">29924488</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo JB, Van Deerlin VM, Lee EB, et al. . A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Alzheimers Dement. 2014;10:477&#x2013;484.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3933464</ArticleId><ArticleId IdType="pubmed">23978324</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur L, Pavlovic-Djuranovic S, Smith-Koutmou K, Green R, Szczesny P DS. Translational control by lysine-encoding A-rich sequences. Sci Adv. 2015;1:e1500154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552401</ArticleId><ArticleId IdType="pubmed">26322332</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrasekaran V, Juszkiewicz S, Choi J, et al. . Mechanism of ribosome stalling during translation of a poly(A) tail. Nat Struct Mol Biol. 2019;26:1132&#x2013;1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6900289</ArticleId><ArticleId IdType="pubmed">31768042</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy E, Leonard M, Mak R, Liao J, Fulzele A, Bennett EJ. ZNF598 and RACK1 regulate mammalian ribosome-associated quality control function by mediating regulatory 40S ribosomal ubiquitylation. Mol Cell. 2017;65:751&#x2013;760.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5321136</ArticleId><ArticleId IdType="pubmed">28132843</ArticleId></ArticleIdList></Reference><Reference><Citation>Udagawa T, Seki M, Okuyama T, et al. . Failure to degrade CAT-tailed proteins disrupts neuronal morphogenesis and cell survival. Cell Rep. 2021;34:108599.</Citation><ArticleIdList><ArticleId IdType="pubmed">33406423</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Arzberger T, Gr&#xe4;sser FA, et al. . Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013;126:881&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Bo&#x17e;i&#x10d; J, Motaln H, Jane&#x17e; AP, et al. . Interactome screening of C9orf72 dipeptide repeats reveals VCP sequestration and functional impairment by polyGA. Brain. 2022;145:684&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9014755</ArticleId><ArticleId IdType="pubmed">34534264</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Morderer D, Wren MC, et al. . Proximity proteomics of C9orf72 dipeptide repeat proteins identifies molecular chaperones as modifiers of poly-GA aggregation. Acta Neuropathol Commun. 2022;10:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8842533</ArticleId><ArticleId IdType="pubmed">35164882</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabet R, Schaeffer L, Freyermuth F, et al. . CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts. Nat Commun. 2018;9:152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5764992</ArticleId><ArticleId IdType="pubmed">29323119</ArticleId></ArticleIdList></Reference><Reference><Citation>McEachin ZT, Gendron TF, Raj N, et al. . Chimeric peptide species contribute to divergent dipeptide repeat pathology in c9ALS/FTD and SCA36. Neuron. 2020;107:292&#x2013;305.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8138626</ArticleId><ArticleId IdType="pubmed">32375063</ArticleId></ArticleIdList></Reference><Reference><Citation>Terrey M, Adamson SI, Gibson AL, et al. . GTPBP1 resolves paused ribosomes to maintain neuronal homeostasis. eLife. 2020;9:1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665888</ArticleId><ArticleId IdType="pubmed">33186095</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoli-Avella AM, Garcia-Aznar JM, Brandau O, et al. . Biallelic inactivating variants in the GTPBP2 gene cause a neurodevelopmental disorder with severe intellectual disability. Eur J Hum Genet. 2018;26:592&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5891495</ArticleId><ArticleId IdType="pubmed">29449720</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Hao X, Cao X, Liu B, Nystr&#xf6;m T. Spatial sequestration and detoxification of huntingtin by the ribosome quality control complex. eLife. 2016;5(e11792):1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868537</ArticleId><ArticleId IdType="pubmed">27033550</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Yang J, Choe YJ, et al. . Role of the ribosomal quality control machinery in nucleocytoplasmic translocation of polyQ-expanded huntingtin exon-1. Biochem Biophys Res Commun. 2017;493:708&#x2013;717.</Citation><ArticleIdList><ArticleId IdType="pubmed">28864412</ArticleId></ArticleIdList></Reference><Reference><Citation>Lytvynenko I, Paternoga H, Thrun A, et al. . Alanine tails signal proteolysis in bacterial ribosome-associated quality control. Cell. 2019;178:76&#x2013;90.e22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6642441</ArticleId><ArticleId IdType="pubmed">31155236</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito S, Hosoda N, Hoshino SI. The Hbs1-Dom34 protein complex functions in non-stop mRNA decay in mammalian cells. J Biol Chem. 2013;288:17832&#x2013;17843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3682582</ArticleId><ArticleId IdType="pubmed">23667253</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogakos T, Morozov P, Garzia A, et al. . The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs. 2017; (May). doi:10.1038/ncomms16056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16056</ArticleId><ArticleId IdType="pmc">PMC5504347</ArticleId><ArticleId IdType="pubmed">28685749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroha K, Zinoviev A, Hellen CUT, Pestova T V. Release of ubiquitinated and non-ubiquitinated nascent chains from stalled mammalian ribosomal complexes by ANKZF1 and Ptrh1. Mol Cell. 2018;72:286&#x2013;302.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344051</ArticleId><ArticleId IdType="pubmed">30244831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Zhang P, Kim HJ, et al. . C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167:774&#x2013;788.e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K, Yagi T, Cammack AJ, et al. . Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation. Hum Mol Genet. 2016;25:1803&#x2013;1813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986334</ArticleId><ArticleId IdType="pubmed">26931465</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonobe Y, Aburas J, Krishnan G, et al. . A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation. Nat Commun. 2021;12:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8519953</ArticleId><ArticleId IdType="pubmed">34654821</ArticleId></ArticleIdList></Reference><Reference><Citation>Green KM, Glineburg MR, Kearse MG, et al. . RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response. Nat Commun. 2017;8:2005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5722904</ArticleId><ArticleId IdType="pubmed">29222490</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H, Hornburg D, Czuppa M, et al. . Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity. Life Sci Alliance. 2018;1:e201800070-&#x2013;13..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6238541</ArticleId><ArticleId IdType="pubmed">30456350</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens TG, Niccoli T, Wilson KM, et al. . C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A. Acta Neuropathol. 2019;137:487&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6514073</ArticleId><ArticleId IdType="pubmed">30604225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Gendron TF, Ebbert MTW, et al. . Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat Med. 2018;24:1136&#x2013;1142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6520050</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer G, Boehringer D, Ban N, Bukau B. The ribosome as a platform for co-translational processing, folding and targeting of newly synthesized proteins. Nat Struct Mol Biol. 2009;16:589&#x2013;597.</Citation><ArticleIdList><ArticleId IdType="pubmed">19491936</ArticleId></ArticleIdList></Reference><Reference><Citation>Osuna BA, Howard CJ KCS, Frost A, Weinberg DE. In vitro analysis of RQC activities provides insights into the mechanism and function of CAT tailing. Hinnebusch AG, ed. eLife. 2017;6:e27949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5562442</ArticleId><ArticleId IdType="pubmed">28718767</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Lehmer C, Mart&#xed;nez-S&#xe1;nchez A, et al. . In situ structure of neuronal C9orf72 poly-GA aggregates reveals proteasome recruitment. Cell. 2018;172:696&#x2013;705.e12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6035389</ArticleId><ArticleId IdType="pubmed">29398115</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi X, Jones T, Abbasi F, et al. . Drosophila caliban, a nuclear export mediator, can function as a tumor suppressor in human lung cancer cells. Oncogene. 2005;24:8229&#x2013;8239.</Citation><ArticleIdList><ArticleId IdType="pubmed">16103875</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>